BridgeMD
New treatment option for Subarachnoid Haemorrhage From Cerebral Aneurism Rupture
Official title Investigating the Tolerability and Feasibility of tVNS Following aSAH
ClinicalTrials.gov ID: NCT06374693
What this study is testing
- What it's testing
- After a subarachnoid haemorrhage, complications are common and increase the overall rate of disability and death from the condition. Despite some advances in preventing, detecting and treating these complications, the rates of complications and associated risks remain high.
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age \>18
- Admitted to STH (Sheffield Teaching Hospital) neurosurgery department
- Confirmed aneurysmal SAH on vascular imaging
- Within 5 days of 'Securing' aneurysm (i.e., successfully coiled or surgically following rupture)
You likely can't join if
- Current or prior use of a vagus nerve stimulation
- Symptomatic bradycardia or PPM insertion
- Complete heart block
- Implantation of any other electrical stimulator (e.g. DBS)
The study team makes the final eligibility decision.
Where it's taking place
- Sheffield, South Yorkshire, United Kingdom
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Sheffield, South Yorkshire, United Kingdom. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.